All News
Trump Administration Asks Court to Dismiss Abortion Pill Case
The request echoes the position the Biden administration took in the case in January, surprising some observers.
Read MoreSTAT+: Vertex reports an earnings miss and pause on cystic fibrosis trial
Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait for its next leg of growth.
Read MoreTime to Drop Confirmatory Testing for Primary Aldosteronism?
(MedPage Today) -- A confirmatory test to verify a primary aldosteronism diagnosis had little clinical value, according to the results of an accuracy study.
Read MoreOne-Size-Fits-All Ranges May Be Misclassifying Thyroid Diseases
(MedPage Today) -- Adjusting the reference intervals of thyroid function diagnostic tests -- for age, sex, and race -- reclassified many people into different disease categories when compared wit
Read More20 Attorneys General Ask Federal Judge to Reverse Deep Cuts to HHS
(MedPage Today) -- Attorneys general in 19 states and Washington, D.C.
Read MoreSTAT+: Charles Lieber, ex-Harvard chemist convicted of lying about ties to China, joins faculty of Chinese university
Charles Lieber, the former chair of Harvard’s chemistry department who was convicted of lying to federal agents about his ties to China, was recently announced as a new professor at a…
Read MoreAs Trump Targets Researchers, Europe Makes a Pitch to Attract Scientists
The continent’s leaders are hoping to benefit as the Trump administration cuts support for research and threatens universities such as Harvard and Columbia with the freezing of federal funds.
Read MoreParamagnetic Rim Lesions and Multiple Sclerosis
(MedPage Today) -- New evidence added to the literature that paramagnetic rim lesions (PRLs) may be a biomarker of disability accumulation in multiple sclerosis (MS).
Read MoreWho Are the Authors of the HHS Report on Gender Dysphoria?
(MedPage Today) -- Noticeably missing from the 400-page report on gender dysphoria issued by HHS late last week were the names of any of its authors.
Read MoreOpinion: STAT+: Bristol Myers Squibb CEO: Pharmaceutical innovation requires bold yet predictable U.S. policy
Bristol Myers Squibb CEO warns against “slashing U.S. investment in medicines or importing lackluster policies of less innovative health care systems.
Read More